Explore Investments LLC/DE - Jul 25, 2025 SCHEDULE 13G Report for Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share (LYEL)

Filing Manager: Explore Investments LLC/DE
Reporting Manager: Explore Investments LLC
Security: Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share
Symbol: LYEL
Shares outstanding: 19.3M shares
Disclosed Ownership: 1.04M shares
Ownership: 5.4%
Form type: SCHEDULE 13G
Date filed: 8/19/2025, 04:10 PM
Date of event: Jul 25, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Explore Investments LLC	5.4%	1.04M	0	1.04M	/s/ Paul Dauber	Paul Dauber/its Manager
Jeffrey P. Bezos	5.4%	1.04M	0	1.04M	/s/ Jeffrey P. Bezos	Jeffrey P. Bezos/an Individual